
    
      This study will evaluate if TLI-ATG conditioning followed by allogeneic hematpoietic cell
      transplant (HCT), which has provided excellent overall survival for patients with relapsed
      lymphoma after failed autologous HCT, provides a similar benefit in the setting of elderly
      patients with hematologic malignancies.
    
  